Innoviva (INVA) Other financing activities (2013 - 2026)
Innoviva posted quarterly Other financing activities of $101000.0 for Q1 2026, down 44.81% year-on-year from $183000.0 in Q1 2025, and down 40.24% on a QoQ basis from $169000.0 in Q3 2025.
Innoviva (INVA) has 14 years of Other financing activities data on file, last reported at $101000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 44.81% year-over-year to $101000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 82.01% YoY), and the FY2025 full-year result was $2.4 million, up 82.02% from the prior year.
- Other financing activities for Q1 2026 stood at $101000.0, down from $169000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.2 million in Q2 2025 and bottomed at -$23000.0 in Q1 2023.
- The 5-year median for Other financing activities is $136000.0 (2024), against an average of $212923.1.
- The widest annual swing landed in 2022, when Other financing activities sank 121.57%; it then soared 2018.18% in 2024.
- A 5-year view of Other financing activities shows it stood at -$11000.0 in 2022, then changed by 0.0% to -$11000.0 in 2023, then jumped by 2018.18% to $211000.0 in 2024, then slipped by 19.91% to $169000.0 in 2025, then plunged by 40.24% to $101000.0 in 2026.
- The last three Other financing activities figures came in at $101000.0 (Q1 2026), $169000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101,000.00 |
| Mar 31, 2026 | 101,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Jun 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 183,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 404,000.00 |
| Mar 31, 2024 | 404,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | 80,000.00 |
| Jun 30, 2023 | 80,000.00 |
| Mar 31, 2023 | -23,000.00 |
| Mar 31, 2023 | -23,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Mar 31, 2022 | 214,000.00 |
| Mar 31, 2022 | 214,000.00 |
| Sep 30, 2021 | 51,000.00 |
| Sep 30, 2021 | 51,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Dec 31, 2020 | 771,000.00 |
| Dec 31, 2020 | 771,000.00 |
| Sep 30, 2020 | -12,000.00 |
| Sep 30, 2020 | -12,000.00 |
| Jun 30, 2020 | 180,000.00 |
| Jun 30, 2020 | 180,000.00 |
| Mar 31, 2020 | 170,000.00 |
| Mar 31, 2020 | 170,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Sep 30, 2019 | 82,000.00 |
| Sep 30, 2019 | 82,000.00 |
| Jun 30, 2019 | 201,000.00 |
| Jun 30, 2019 | 201,000.00 |
| Mar 31, 2019 | 254,000.00 |
| Mar 31, 2019 | 254,000.00 |
| Dec 31, 2018 | -1.93 Mn |
| Dec 31, 2018 | -1.93 Mn |
| Sep 30, 2018 | -242,000.00 |
| Sep 30, 2018 | -242,000.00 |
| Jun 30, 2018 | 111,000.00 |
| Jun 30, 2018 | 111,000.00 |
| Mar 31, 2018 | -2.50 Mn |
| Mar 31, 2018 | -2.50 Mn |
| Sep 30, 2017 | 12.80 Mn |
| Sep 30, 2017 | 12.80 Mn |
| Dec 31, 2016 | 187,000.00 |
| Dec 31, 2016 | 187,000.00 |
| Dec 31, 2015 | -480,000.00 |
| Dec 31, 2015 | -480,000.00 |
| Dec 31, 2014 | 5.60 Mn |
| Dec 31, 2014 | 5.60 Mn |
| Sep 30, 2014 | 8.63 Mn |
| Sep 30, 2014 | 8.63 Mn |
| Dec 31, 2013 | 26.99 Mn |
| Dec 31, 2013 | 26.99 Mn |